Palo Alto Stocks Boosted by Contract News, Abbott Labs Braces for Ruling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Jim Cramer
Danaher puts bioprocessing back into growth. We are raising our rating to buy
Danaher shares fell on Tuesday even though the life sciences company regained growth in its key bioprocessing business in the…
Abbott Labs shines with strong quarter and buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and raised its profit forecasts for the third consecutive…
GE Healthcare has been an under-the-radar winner and a new catalyst has just arrived
GE Healthcare's quiet outperformance is becoming harder to ignore, and its new drug used in radiology to improve the diagnosis…
10 things to watch in the stock market on Friday, including a bullish call on Best Buy
Ten Things to Watch for Friday, September 27 1. The S&P 500 was pointing to a slightly higher open on…
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
GE Healthcare shows signs of life, but lingering uncertainty keeps us on the sidelines
Each weekday, the CNBC Investing Club with Jim Cramer publishes the home stretch, a handy evening update, just in time…
We're making nearly 300% gains on a rising pharmaceutical stock
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
Jim Cramer discusses the reasons for the market crash and three factors that influenced stock performance
Each weekday, CNBC's Investment Club with Jim Cramer publishes the final stretch, an action-packed afternoon update just in time for…
Jim Cramer says Vornado's double modernization is a sign that the city's real estate sector is back
Jim Cramer's daily quick analysis of stocks making the news outside of the CNBC Investing Club portfolio. Lowe's: The home…